Jianming Xu
1992–2026 年に発表
- 375
- 論文数
- 63,616
- 被引用数
- 121
- h 指数
- 339
- i10 指数
被引用数
引用元
国・地域
機関
分野
- Medicine49.4%
- Biochemistry, Genetics and Molecular Biology23.9%
- Environmental Science12.4%
- Immunology and Microbiology2.6%
- Agricultural and Biological Sciences2.4%
- Engineering2.1%
- その他7.2%
トピック
- Hepatocellular Carcinoma Treatment and Prognosis5%
- Cancer Immunotherapy and Biomarkers3.5%
- Gastric Cancer Management and Outcomes2.4%
- Heavy metals in environment1.9%
- Cholangiocarcinoma and Gallbladder Cancer Studies1.7%
- Cancer Mechanisms and Therapy1.6%
- その他83.9%
共著者
全論文
- Sintilimab plus a bevacizumab biosimilar (IBI305) versus sorafenib in unresectable hepatocellular carcinoma (ORIENT-32): a randomised, open-label, phase 2–3 study
著者: Zhenggang Ren, Jianming Xu, Yuxian Bai, Aibing Xu, Shundong Cang, Chengyou Du, Qiu Li, Yinying Lu, Yajin Chen, Yabing Guo, Zhendong Chen, Baorui Liu, Weidong Jia, Jian Wu, Junye Wang, Guoliang Shao, Bixiang Zhang, Yunfeng Shan, Zhiqiang Meng, Jianbing Wu, Shanzhi Gu, Wei Yang, Chao Liu, Xuetao Shi, Zhenyuan Gao, Tao Yin, Jiuwei Cui, Ming Huang, Bao-Cai Xing, Yilei Mao, Gao‐Jun Teng, Yanru Qin, Jinhai Wang, Feng Xia, Guowen Yin, Yong Yang, Mingxia Chen, Yan Wang, Hui Zhou, Jia Fan - The Lancet Oncology 2021 被引用: 1,115
- Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trial
著者: Ann‐Lii Cheng, Yoon‐Koo Kang, Zhendong Chen, Chao-Jung Tsao, Shukui Qin, Jun Suk Kim, Rongcheng Luo, Jifeng Feng, Sheng‐Long Ye, Tsai‐Sheng Yang, Jianming Xu, Yan Sun, Houjie Liang, Jiwei Liu, Jiejun Wang, Won Young Tak, Hongming Pan, K. Burock, Jessie Zou, D. Voliotis, Zhongzhen Guan - The Lancet Oncology 2008 被引用: 5,842
- Zolbetuximab plus mFOLFOX6 in patients with CLDN18.2-positive, HER2-negative, untreated, locally advanced unresectable or metastatic gastric or gastro-oesophageal junction adenocarcinoma (SPOTLIGHT): a multicentre, randomised, double-blind, phase 3 trial
著者: Kohei Shitara, Florian Lordick, Yung‐Jue Bang, Peter C. Enzinger, David H. Ilson, Manish A. Shah, Eric Van Cutsem, Rui‐Hua Xu, Giuseppe Aprile, Jianming Xu, Joseph Chao, Roberto Pazo-Cid, Yoon‐Koo Kang, Jianning Yang, Diarmuid Moran, Pranob Bhattacharya, Ahsan M. Arozullah, Jung Wook Park, Mok Oh, Jaffer A. Ajani - The Lancet 2023 被引用: 711
- Nivolumab Combination Therapy in Advanced Esophageal Squamous-Cell Carcinoma
著者: Yuichiro Doki, Jaffer A. Ajani, Ken Kato, Jianming Xu, Lucjan Wyrwicz, Satoru Motoyama, Takashi Ogata, Hisato Kawakami, Chih-Hung Hsu, Antoine Adenis, Farid El Hajbi, Maria Di Bartolomeo, Maria I. Braghiroli, Eva Holtved, Sandra A. Ostoich, Hye R. Kim, Masaki Ueno, Wasat Mansoor, Wen-Chi Yang, Tianshu Liu, John Bridgewater, Tomoki Makino, Ioannis Xynos, Xuan Liu, Ming Lei, Kaoru Kondo, Apurva Patel, Joseph Gricar, Ian Chau, Yuko Kitagawa - New England Journal of Medicine 2022 被引用: 1,181
- The KEYNOTE-811 trial of dual PD-1 and HER2 blockade in HER2-positive gastric cancer
著者: Yelena Y. Janjigian, Akihito Kawazoe, Patricio Yañez, Ning Li, Sara Lonardi, О. P. Коlesnik, Olga Barajas, Yuxian Bai, Lin Shen, Yong Tang, Lucjan Wyrwicz, Jianming Xu, Kohei Shitara, Shukui Qin, Eric Van Cutsem, Josep Tabernero, Lie Li, Sukrut Shah, Pooja Bhagia, Hyun Cheol Chung - Nature 2021 被引用: 709
- Guidelines for the Diagnosis and Treatment of Hepatocellular Carcinoma (2019 Edition)
著者: Jian Zhou, Hui‐Chuan Sun, Zheng Wang, Wen‐Ming Cong, Jianhua Wang, Mengsu Zeng, Weiping Zhou, Ping Bie, Lianxin Liu, Tianfu Wen, Guohong Han, Maoqiang Wang, Ruibao Liu, Ligong Lu, Zhengang Ren, Minshan Chen, Zhao‐Chong Zeng, Ping Liang, Changhong Liang, Min Chen, Fuhua Yan, Wen‐Ping Wang, Yuan Ji, Jing‐Ping Yun, Dingfang Cai, Yongjun Chen, Wenwu Cheng, Shuqun Cheng, Chaoliu Dai, Wenzhi Guo, Baojin Hua, Xiaowu Huang, Weidong Jia, Yaming Li, Ye‐Xiong Li, Jun Liang, Tianshu Liu, Guoyue Lv, Yilei Mao, Tao Peng, Weixin Ren, Hongcheng Shi, Guo‐Ming Shi, Kaishan Tao, Wentao Wang, Xiaoying Wang, Zhiming Wang, Bang‐De Xiang, Baocai Xing, Jianming Xu, Jiamei Yang, Jianyong Yang, Yefa Yang, Yunke Yang, Sheng‐Long Ye, Zhengyu Yin, Bixiang Zhang, Boheng Zhang, Leida Zhang, Shuijun Zhang, Ti Zhang, Yongfu Zhao, Honggang Zheng, Jiye Zhu, Kangshun Zhu, Rong Liu, Ying–Hong Shi, Yong‐Sheng Xiao, Zhi Dai, Gao‐Jun Teng, Jianqiang Cai, Weilin Wang, Xiujun Cai, Qiang Li, Feng Shen, Shukui Qin, Jiahong Dong, Jia Fan - Liver Cancer 2020 被引用: 833
- Pembrolizumab plus trastuzumab and chemotherapy for HER2-positive gastric or gastro-oesophageal junction adenocarcinoma: interim analyses from the phase 3 KEYNOTE-811 randomised placebo-controlled trial
著者: Yelena Y. Janjigian, Akihito Kawazoe, Yuxian Bai, Jianming Xu, Sara Lonardi, Jean Phillipe Metges, Patricio Yañez, Lucjan Wyrwicz, Lin Shen, Yuriy Ostapenko, Mehmet Bilici, Hyun Cheol Chung, Kohei Shitara, Shukui Qin, Eric Van Cutsem, Josep Tabernero, Kan Li, Chie‐Schin Shih, Pooja Bhagia, Sun Young Rha - The Lancet 2023 被引用: 467
- Nivolumab Combination Therapy in Advanced Esophageal Squamous-Cell Carcinoma
著者: Yuichiro� Doki, Jaffer A. Ajani, Ken Kato, Jianming Xu, Lucjan Wyrwicz, Satoru Motoyama, Takashi Ogata, Hisato Kawakami, Chih‐Hung Hsu, Antoine Adenis, Farid El Hajbi, Maria Di Bartolomeo, Maria Ignez Braghiroli, Eva Holtved, Sandra A. Ostoich, Hye R. Kim, Masaki Ueno, Wasat Mansoor, Wen‐Chi Yang, Tianshu Liu, John Bridgewater, Tomoki Makino, Ioannis Xynos, Xuan Liu, Ming Lei, Kaoru Kondo, Apurva Patel, Joseph Gricar, Ian Chau, Yuko Kitagawa, Doki, Yuichiro, Ajani, Jaffer A., Kato, Ken, Xu, Jianming, Wyrwicz, Lucjan, Motoyama, Satoru, Ogata, Takashi, Kawakami, Hisato, Hsu, Chih Hung, Adenis, Antoine, Di Bartolomeo, Maria, Braghiroli, Maria I., Holtved, Eva, Ostoich, Sandra A., Kim, Hye R., Ueno, Masaki, Mansoor, Wasat, Yang, Wen Chi, Liu, Tianshu, Bridgewater, John, Makino, Tomoki, Xynos, Ioannis, Liu, Xuan, Lei, Ming, Kondo, Kaoru, Patel, Apurva, Gricar, Joseph, Chau, Ian, Kitagawa, Yuko - 2022 被引用: 532
- Guidelines for the Diagnosis and Treatment of Primary Liver Cancer (2022 Edition)
著者: Jian Zhou, Hui‐Chuan Sun, Zheng Wang, Wen‐Ming Cong, Mengsu Zeng, Weiping Zhou, Ping Bie, Lianxin Liu, Tianfu Wen, Ming Kuang, Guohong Han, Zhiping Yan, Maoqiang Wang, Ruibao Liu, Ligong Lu, Zhenggang Ren, Zhaochong Zeng, Ping Liang, Changhong Liang, Min Chen, Fuhua Yan, Wen‐Ping Wang, Jinlin Hou, Yuan Ji, Jing‐Ping Yun, Xueli Bai, Dingfang Cai, Weixia Chen, Yongjun Chen, Wenwu Cheng, Shuqun Cheng, Chaoliu Dai, Wenzhi Guo, Yabing Guo, Baojin Hua, Xiaowu Huang, Weidong Jia, Qiu Li, Tao Li, Xun Li, Yaming Li, Ye‐Xiong Li, Jun Liang, Changquan Ling, Tianshu Liu, Xiufeng Liu, Shichun Lu, Guoyue Lv, Yilei Mao, Zhiqiang Meng, Tao Peng, Weixin Ren, Hongcheng Shi, Guo‐Ming Shi, Ming Shi, Tianqiang Song, Kaishan Tao, Jianhua Wang, Kui Wang, Lu Wang, Wentao Wang, Xiaoying Wang, Zhiming Wang, Bang‐De Xiang, Baocai Xing, Jianming Xu, Jiamei Yang, Yang Jianyong, Yefa Yang, Yunke Yang, Sheng‐Long Ye, Zhen‐Yu Yin, Yong Zeng, Bixiang Zhang, Boheng Zhang, Leida Zhang, Shuijun Zhang, Ti Zhang, Yanqiao Zhang, Ming Zhao, Yongfu Zhao, Honggang Zheng, Ledu Zhou, Jiye Zhu, Kangshun Zhu, Rong Liu, Ying–Hong Shi, Yong‐Sheng Xiao, Lan Zhang, Chun Yang, Zhifeng Wu, Zhi Dai, Minshan Chen, Jianqiang Cai, Weilin Wang, Xiujun Cai, Q. Li, Feng Shen, Shukui Qin, Gao‐Jun Teng ほか 2 名 - Liver Cancer 2023 被引用: 452
- Sintilimab Plus Chemotherapy for Unresectable Gastric or Gastroesophageal Junction Cancer
著者: Jianming Xu, Haiping Jiang, Yueyin Pan, Kangsheng Gu, Shundong Cang, Lei Han, Yongqian Shu, Jiayi Li, Junhui Zhao, Hongming Pan, Suxia Luo, Yanru Qin, Qunyi Guo, Yuxian Bai, Ling Yang, Jianwei Yang, Zhilong Yan, Lei Yang, Yong Tang, Yifu He, Liangming Zhang, Xinjun Liang, Zuoxing Niu, Jingdong Zhang, Yong Mao, Yingmei Guo, Bo Peng, Ziran Li, Ying Liu, Yan Wang, Hui Zhou, ORIENT-16 Investigators, Hongmei Sun, Qi Wang, Junhe Li, Da Jiang, Weijian Guo, Jieer Ying, Shubin Wang, Aimin Zang, Shirong Cai, Chunhong Hu, Tao Zhang, Min Tao, Jun Liang, Qinsheng Mao, Minghui Zhang, Rui Mao, Hui Yang, Hongyu Zhang, Lin Shen, Jin Lu, Wenxin Li, Yamin Chen, Lei Chen, Zhixiang Zhuang, Chunmei Bai, Heli Liu, Jingtang Chen, Wangjun Liao, Meng Qiu, Rongfeng Song, Man Li, S. B. Qian, Yunpeng Liu, Jiang Liu, Dong Wang, Xianli Yin, Zhiming Huang - JAMA 2023 被引用: 357
- Camrelizumab versus investigator's choice of chemotherapy as second-line therapy for advanced or metastatic oesophageal squamous cell carcinoma (ESCORT): a multicentre, randomised, open-label, phase 3 study
著者: Jing Huang, Jianming Xu, Yun Chen, Wu Zhuang, Yiping Zhang, Zhendong Chen, Jia Chen, Helong Zhang, Zuoxing Niu, Qingxia Fan, Lizhu Lin, Kangsheng Gu, Ying Liu, Yi Ba, Zhanhui Miao, Xiaodong Jiang, Ming Zeng, Jianhua Chen, Zhichao Fu, Lu Gan, Jun Wang, Xianbao Zhan, Tianshu Liu, Zhiping Li, Lin Shen, Yongqian Shu, Tao Zhang, Qing Yang, Jianjun Zou, Suxia Luo, Feng Peng, Gang Wu, Nong Xu, Lin Zhao, Dong Ma, Shukui Qin, Wei Ren, Enxiao Li, Hongda Lu, Yueyin Pan, Jianping Xiong, Ying Yuan, Yuxian Bai, Lei Chen, Yi Hu, Li Zhang, Yong Gao - The Lancet Oncology 2020 被引用: 584
- Neoadjuvant and adjuvant pembrolizumab plus chemotherapy in locally advanced gastric or gastro-oesophageal cancer (KEYNOTE-585): an interim analysis of the multicentre, double-blind, randomised phase 3 study
著者: Kohei Shitara, Sun Young Rha, Lucjan Wyrwicz, Takashi Oshima, Nina Karaseva, M. A. Osipov, Hisateru Yasui, Hiroshi Yabusaki, S. G. Afanasyev, Young Kyu Park, Salah-Eddin Al-Batran, Takaki Yoshikawa, Patricio Yañez, Maria Di Bartolomeo, Sara Lonardi, Josep Tabernero, Eric Van Cutsem, Yelena Y. Janjigian, Do‐Youn Oh, Jianming Xu, Xiao Fang, Chie‐Schin Shih, Pooja Bhagia, Yung‐Jue Bang - The Lancet Oncology 2023 被引用: 339
- Camrelizumab in Combination with Apatinib in Patients with Advanced Hepatocellular Carcinoma (RESCUE): A Nonrandomized, Open-label, Phase II Trial
著者: Jianming Xu, Jie Shen, Shanzhi Gu, Yun Zhang, Lihua Wu, Jian Wu, Guoliang Shao, Yanqiao Zhang, Li Xu, Tao Yin, Jingfeng Liu, Zhenggang Ren, Jianping Xiong, Xianhai Mao, Ling Zhang, Jiayin Yang, Le‐Qun Li, Xiaoming Chen, Zhiming Wang, Kangsheng Gu, Xi Chen, Zhanyu Pan, Kuansheng Ma, Xinmin Zhou, Zujiang Yu, Enxiao Li, Guowen Yin, Xiao Zhang, Shuni Wang, Quanren Wang - Clinical Cancer Research 2020 被引用: 572
- Geographic patterns of co-occurrence network topological features for soil microbiota at continental scale in eastern China
著者: Bin Ma, Haizhen Wang, Melissa Dsouza, Jun Lou, Yan He, Zhongmin Dai, Philip C. Brookes, Jianming Xu, Jack A. Gilbert - The ISME Journal 2016 被引用: 1,281
- Incidence and Etiology of Drug-Induced Liver Injury in Mainland China
著者: Tao Shen, Yingxia Liu, Jia Shang, Qing Xie, Jun Li, Ming Yan, Jianming Xu, Junqi Niu, Jiajun Liu, Paul B. Watkins, Guruprasad P. Aithal, Raúl J. Andrade, Xiaoguang Dou, Lvfeng Yao, Fangfang Lv, Qi Wang, Yongguo Li, Xinmin Zhou, Yuexin Zhang, Peilan Zong, Bin Wan, Zhengsheng Zou, Dongliang Yang, Yuqiang Nie, Dongliang Li, Yuya Wang, Xian Han, Hui Zhuang, Yimin Mao, Chengwei Chen - Gastroenterology 2019 被引用: 612
- Tislelizumab plus chemotherapy versus placebo plus chemotherapy as first-line treatment for advanced or metastatic oesophageal squamous cell carcinoma (RATIONALE-306): a global, randomised, placebo-controlled, phase 3 study
著者: Jianming Xu, Ken Kato, Eric Raymond, Richard Hubner, Yongqian Shu, Yueyin Pan, Sook Ryun Park, Lu Ping, Yi Jiang, Jingdong Zhang, Xiaohong Wu, Yuanhu Yao, Lin Shen, Takashi Kojima, Evgeny Gotovkin, Ryu Ishihara, Lucjan Wyrwicz, Eric Van Cutsem, Paula Jiménez‐Fonseca, Chen‐Yuan Lin, Lei Wang, Jingwen Shi, Liyun Li, Harry H. Yoon - The Lancet Oncology 2023 被引用: 291
- Effect of Fruquintinib vs Placebo on Overall Survival in Patients With Previously Treated Metastatic Colorectal Cancer
著者: Jin Li, Shukui Qin, Rui‐Hua Xu, Lin Shen, Jianming Xu, Yuxian Bai, Lei Yang, Yanhong Deng, Zhen-dong Chen, Haijun Zhong, Hongming Pan, Weijian Guo, Yongqian Shu, Ying Yuan, Jianfeng Zhou, Nong Xu, Tianshu Liu, Dong Ma, Changping Wu, Ying Cheng, Donghui Chen, Wei Li, Sanyuan Sun, Zhuang Yu, Peiguo Cao, Haihui Chen, Jiejun Wang, Shubin Wang, Hongbing Wang, Songhua Fan, Hua Ye, Weiguo Su - JAMA 2018 被引用: 404
- Randomized, Double-Blind, Placebo-Controlled Phase III Trial of Apatinib in Patients With Chemotherapy-Refractory Advanced or Metastatic Adenocarcinoma of the Stomach or Gastroesophageal Junction
著者: Jin Li, Shukui Qin, Jianming Xu, Jianping Xiong, Changping Wu, Yuxian Bai, Wei Liu, Jiandong Tong, Yunpeng Liu, Rui‐Hua Xu, Zhehai Wang, Qiong Wang, Xuenong Ouyang, Yan Yang, Yi Ba, Jun Liang, Xiaoyan Lin, Deyun Luo, Rongsheng Zheng, Xin Wang, Guoping Sun, Liwei Wang, Leizhen Zheng, Hong Guo, Jingbo Wu, Nong Xu, Jianwei Yang, Honggang Zhang, Ying Cheng, Ningju Wang, Lei Chen, Zhining Fan, Piaoyang Sun, Hao Yu - Journal of Clinical Oncology 2016 被引用: 997
- Earth microbial co-occurrence network reveals interconnection pattern across microbiomes
著者: Bin Ma, Yiling Wang, Shudi Ye, Shan Liu, Erinne Stirling, Jack A. Gilbert, Karoline Faust, Rob Knight, Janet Jansson, César Cardona, Lisa Röttjers, Jianming Xu - Microbiome 2020 被引用: 578
- Long-term care system for older adults in China: policy landscape, challenges, and future prospects
著者: Zhanlian Feng, Elena Glinskaya, Hongtu Chen, Sen Gong, Yue Qiu, Jianming Xu, Winnie Yip - The Lancet 2020 被引用: 643
- Efficacy and safety of a novel anti‐HER2 therapeutic antibody RC48 in patients with HER2‐overexpressing, locally advanced or metastatic gastric or gastroesophageal junction cancer: a single‐arm phase II study
著者: Zhi Peng, Tianshu Liu, Jia Wei, Airong Wang, Yifu He, Liuzhong Yang, Xizhi Zhang, Nanfeng Fan, Suxia Luo, Zhen Li, Kangsheng Gu, Jianwei Lu, Jianming Xu, Qingxia Fan, Rui‐Hua Xu, Liangming Zhang, Enxiao Li, Yuping Sun, Guohua Yu, Chunmei Bai, Yong Liu, Jiangzheng Zeng, Jieer Ying, Xinjun Liang, Nong Xu, Chao Gao, Yongqian Shu, Dong Ma, Guanghai Dai, Shengmian Li, Ting Deng, Yuehong Cui, Jianmin Fang, Yi Ba, Lin Shen - Cancer Communications 2021 被引用: 202
- Regorafenib plus best supportive care versus placebo plus best supportive care in Asian patients with previously treated metastatic colorectal cancer (CONCUR): a randomised, double-blind, placebo-controlled, phase 3 trial
著者: Jin Li, Shukui Qin, Rui‐Hua Xu, Thomas Yau, Brigette Ma, Hongming Pan, Jianming Xu, Yuxian Bai, Yihebali Chi, Liwei Wang, Kun‐Huei Yeh, Feng Bi, Ying Cheng, Anh T. Le, Jen-Kou Lin, Tianshu Liu, Dong Ma, Christian Kappeler, J. Kalmus, Tae Won Kim - The Lancet Oncology 2015 被引用: 816
- Apatinib as second-line or later therapy in patients with advanced hepatocellular carcinoma (AHELP): a multicentre, double-blind, randomised, placebo-controlled, phase 3 trial
著者: Shukui Qin, Li Qiu, Shanzhi Gu, Xiaoming Chen, Li-zhu Lin, Zishu Wang, Aibing Xu, Xi Chen, Cuncai Zhou, Zhenggang Ren, Lin Yang, Li Xu, Yuxian Bai, Lei Chen, Jun Li, Hongming Pan, Bangwei Cao, Weijia Fang, Wei Wu, Ge Wang, Ying Cheng, Zhuang Yu, Xu Zhu, Da Jiang, Yinying Lu, Huaming Wang, Jianming Xu, Li Bai, Yunpeng Liu, Hailan Lin, Changping Wu, Yang Zhang, Ping Yan, Chunlei Jin, Jianjun Zou - The Lancet. Gastroenterology & hepatology 2021 被引用: 254
- AgentCPM-GUI: Building Mobile-Use Agents with Reinforcement Fine-Tuning
著者: Zhong Zhang, Yaxi Lu, Yikun Fu, Yupeng Huo, Shenzhi Yang, Yesai Wu, Han Si, Xin Cong, Haotian Chen, Yankai Lin, Jie Xie, Wei Zhou, Wang Xu, Yuanheng Zhang, Zhou Su, Zhongwu Zhai, Xiaoming Liu, Yudong Mei, Jianming Xu, Hongyan Tian, Chongyi Wang, Chi Chen, Yuan Yao, Zhiyuan Liu, Maosong Sun - Conference on Empirical Methods in Natural Language Processing: System Demonstrations, EMNLP (System Demonstrations) 2025 被引用: 44
